Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,344.00
(
-1.59%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.44
(
3.84%
)
Bitcoin
70,464.00
(
0.81%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RockRat

Send PM Follow Ignore
Followers 10
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

RockRat

Re: DewDiligence post# 220145

Monday, 07/23/2018 10:24:58 AM

Monday, July 23, 2018 10:24:58 AM

Post# of 257264
RETA: The real surprise to me wasn't the efficacy, it was the very clean looking safety. There might be safety issues with long term use, but accelerated approval looks possible. If achieved, the drug will be on the market for at least a while before said signal shows, if it does. Admittedly a convincing win for the company and longs, and hopefully for patients, too.

Regards, RockRat
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today